Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Other 1Breast 1

Conditions

Prostatic Neoplasms 2Weight Loss 1Obesity 1Lymphedema 1Breast Neoplasms 1

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Weight Reduction Programs × Clear all
NCT03261271 2025-04-13

WARRIOR

University of Kansas Medical Center

Phase NA Completed
40 enrolled 19 charts
GenitourinaryOther

Obesity, Prostatic Neoplasms

NCT04974268 2025-02-14

EJERDIETLIF

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

Phase NA Completed
100 enrolled
Breast

Breast Neoplasms, Lymphedema

NCT02252484 2016-09-07

Energy Balance for Prostate Cancer Survivorship

University of Kansas Medical Center

Phase NA Completed
20 enrolled
Genitourinary

Prostatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡